DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Minimal residual disease
Minimal residual disease
Minimal Residual Disease Detection in Childhood Precursor–B-Cell Acute Lymphoblastic Leukemia: Relation to Other Risk Factors
Mrd)
Effect of the Philadelphia Chromosome on Minimal Residual Disease In
REVIEW Clinical Relevance of Minimal Residual Disease Monitoring in Non
How Close Are We to Incorporating Measurable Residual Disease Into
Cancer and the Immune System an Overview of Recent Publications Featuring Illumina® Technology 2 Cancer and the Immune System TABLE of CONTENTS
Minimal Residual Disease Detection in Mantle Cell Lymphoma
Regulatory Considerations for Use of Minimal Residual Disease in Development of Drug and Biological Products for Treatment Guidance for Industry
Monitoring Minimal Residual Disease and Predicting Relapse in APL By
Minimal Residual Disease (MRD) AHS-M2175
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions
Molecular Detection of Minimal Residual Disease Is a Strong Predictive Factor of Relapse in Childhood B-Lineage Acute Lymphoblastic Leukemia with Medium Risk Features
Genomics, Transcriptomics, and Minimal Residual Disease Detection
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
Minimal Residual Disease in Peripheral Blood at Day 15 Identifies a Subgroup of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia with Superior Prognosis
Minimal Residual Disease in Multiple Myeloma
Minimal Residual Disease (MRD)
Top View
What Is Minimal Residual Disease (MRD)?
Monitoring of Residual Disease by Next-Generation Deep-Sequencing of RUNX1 Mutations Can Identify Acute Myeloid Leukemia Patients with Resistant Disease
Molecular and Cellular Markers for Measurable Residual Disease in Acute Lymphoblastic Leukemia
Letters to the Editor
Minimal Disease Monitoring in Pediatric Non-Hodgkin's
Chromosome Breakpoints and Detection of Minimal Residual Disease
Role of Circulating Tumor DNA in Hematological Malignancy
SYNOPSIS Detection of Minimal Residual Disease in Acute
Detection of Minimal Residual Disease in B Cell Acute
Detection of Minimal Residual Disease in Leukemic Patients with the T(10;14)(Q24;Qll) Chromosomal Translocation1
Evidence-Based Focused Review
Acute Promyelocytic Leukemia: a Constellation of Molecular Events Around a Single PML-RARA Fusion Gene
Advances in the Assessment of Minimal Residual Disease in Mantle Cell Lymphoma Dayoung Jung1, Preetesh Jain1,2, Yixin Yao1 and Michael Wang1*
©Ferrata Storti Foundation
ETV6 Mutations and Loss in AML-M0
University of Birmingham Minimal/Measurable Residual
The Current Status of Minimal Residual Disease Assessment in Myeloma
Minimal Residual Disease in Hematologic Malignancies Acute Lymphoblastic Leukemia – Pathophysiology and Epidemiology
Acute Lymphoblastic Leukemia and Minimal Residual Disease
BRIEF COMMUNICATION Evaluation of Minimal Residual
Minimal Residual Disease in Acute Lymphoblastic Leukaemia
Minimal Residual Disease and Survival Outcomes in Patients With
Defining Minimal Residual Disease in Acute Myeloid Leukemia
Personalized Medicine in Lymphoma: Tailoring Treatment According to Minimal Residual Disease
Relationship Between Minimal Residual Disease Measured By
Minimal/Measurable Residual Disease (MRD) Chart
Clinical Outcomes Based on Measurable Residual Disease Status in Patients with Core-Binding Factor Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis
The Dynamics of RUNX1-RUNX1T1 Transcript Levels After Allogeneic
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome After High-Dose Chemotherapy
Flow Cytometry and IG/TCR Quantitative PCR for Minimal